{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kamada Ltd."},"Symbol":{"label":"Symbol","value":"KMDA"},"Address":{"label":"Address","value":"2 HOLZMAN STREET,P.O. BOX 4081, REHOVOT, 7670402, Israel"},"Phone":{"label":"Phone","value":"+972 89406472"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics."},"CompanyUrl":{"label":"Company Url","value":"https://www.kamada.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Amir London","title":"Chief Executive Officer"},{"name":"Eran Nir","title":"Chief Operating Officer"},{"name":"Naveh Tov","title":"VP-Clinical Development & Medical Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}